Piers A Barry, MD
Orthopedic Surgery · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 9
- 1 carrier
- Offices
- 2
- Since medical school
- 21 years
- Graduated 2005
Offices
2 locations
Hospitals listed: Marinhealth Medical Center · Novato Community Hospital. That is not proof they admit you there this week.
Plans that list them
9 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Barry’s office at (415) 610-2702 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A98300 · Current
Licensed to practise in California · since 2006 · expires 2028-08-31 · University of Southern California Keck School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Orthopaedic Surgery - Orthopaedic Surgery
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Marinhealth Medical CenterGreenbrae, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of MarinHealthPatients rate it 3 of 5 · 76% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.66 (3.59 to 7.73) · 1,505 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.177, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025
- Novato Community HospitalNovato, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 84% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0, Oct 2024 – Sep 2025
See every measure and the patient survey for Marinhealth Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 3 better, 8 the same, 0 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.66 (3.59 to 7.73) · 1,505 cases | Worse | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.177 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.85 (0 to 1.83) · 1,056 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.04 (0.72 to 1.36) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.34 (112.58 to 222.09) · 57 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.9 · 47 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.5 · 119 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.6 · 257 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.5 · 428 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 11.4 · 477 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.3 · 197 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.1 · 2,827 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.38) · 6,990 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.41) · 6,838 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.41 (0 to 3) · 664 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.86 (1.4 to 4.33) · 1,436 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.38 (3.68 to 17.08) · 705 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.38 (0.72 to 8.04) · 672 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.66 (0.18 to 3.15) · 300 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.56 (0 to 1.25) · 5,550 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.4 · 76 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.396 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 275 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22 · 427 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -20.3 · 289 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 3.3 · 494 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -4.9 · 499 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.9 · 435 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.5 (3.6 to 8.4) · 93 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.2 (7.8 to 16) · 93 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.6 · 84 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.5 · 53 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 111 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (10.3 to 16.5) · 2,119 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.4) · 670 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,233 patients answered, 19% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 68% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 74% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 72% |
| Doctors "always" treated them with courtesy and respect | 80% |
| Patients who gave a rating of "9" or "10" (high) | 72% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 68% |
| Nurses "always" listened carefully | 68% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 48% |
| "YES", patients would definitely recommend the hospital | 76% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
See every measure and the patient survey for Novato Community Hospital
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 0 better, 3 the same, 0 worse of 3 measures. Readmissions: 0 better, 7 the same, 0 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1 (0 to 2.06) · 213 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.85 (0.4 to 1.3) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.2 · 25 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10 · 111 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 16.1 · 140 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.3 · 42 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.8 · 627 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.43) · 1,872 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.04 to 0.46) · 1,796 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.92 (0.5 to 5.33) · 505 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.64 (0 to 3.36) · 317 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.2 (0.51 to 3.88) · 495 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.93 (0 to 17.29) · 323 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.88 (0.69 to 9.07) · 311 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.75 (0.22 to 3.27) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.41 (0 to 1.49) · 1,320 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.2 · 143 cases | None | Apr 2023 – Mar 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.6 · 108 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -31.9 · 121 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.1 · 150 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.6 · 143 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 118 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 27 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.5 (9.5 to 16.5) · 930 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.3) · 184 cases | No different | Jan 2024 – Dec 2024 |
What patients said (334 patients answered, 30% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 78% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 83% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 78% |
| Doctors "always" listened carefully | 84% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 82% |
| Staff "always" explained new medications | 77% |
| Nurses "always" explained things so they could understand | 76% |
| Nurses "always" listened carefully | 82% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 84% |
| Staff "always" explained possible side effects | 49% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$212,420
Medicare paid this office $212,420 for 165 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Hyaluronan or derivative, monovisc, for intra-articular injection, per dose | 59 | $59,139 | None |
| Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg | 41 | $31,387 | None |
| Return visit (30+ min) | 89 | $27,215 | $113 |
| Long return visit (40+ min) | 77 | $21,079 | $153 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 57 | $13,211 | $98 |
See all 13 services
| Hyaluronan or derivative, monovisc, for intra-articular injection, per dose | 59 | $59,139 | None |
| Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg | 41 | $31,387 | None |
| Return visit (30+ min) | 89 | $27,215 | $113 |
| Long return visit (40+ min) | 77 | $21,079 | $153 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 57 | $13,211 | $98 |
| New patient visit (60+ min) | 61 | $11,330 | $186 |
| Complete ultrasound scan of joint | 63 | $7,199 | $50 |
| Aspiration and/or injection of fluid from large joint | 59 | $7,012 | $64 |
| New patient visit (45+ min) | 16 | $2,199 | $137 |
| Imaging guidance for procedure, 60 minutes or less | 40 | $2,113 | $41 |
| Mri scan of leg joint without contrast | 25 | $1,537 | $57 |
| Mri scan of arm joint without contrast | 21 | $1,301 | $57 |
| Injection, lidocaine hcl for intravenous infusion, 10 mg | 33 | $1 | None |
Procedures Medicare counted
| Lower limb (leg) arthroscopy (minimally invasive joint repair) | 14 | More than 86% of doctors who do this |
| Upper limb (arm) arthroscopy (minimally invasive joint repair) | 1-10 | None |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 238 | 243 | 292 | 311 | 252 | 135 |
| Aspiration and/or injection of fluid from large joint | – | – | – | 21 | 44 | 110 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
165 Original Medicare patients in 2024. Average age 74 · Women 63% · Health risk score 0.81. At or below the middle of the specialty; the typical orthopedic surgery clinician is at 1.13.
Conditions among them: High blood pressure 47% · Coronary heart disease 19% · Depression 19% · Cancer 15% · Atrial fibrillation 13% · Chronic kidney disease 12% · Diabetes 9%.
The office billed $575,914, Medicare allowed $274,031 and paid $212,420; for 4,805 services of 63 kinds; $104,946 of it was for drugs given in the office and $107,473 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 165 | 4,805 | 74 | 0.81 | $575,914 | $212,420 |
| 2023 | 149 | 7,260 | 74 | 0.86 | $927,127 | $199,308 |
| 2022 | 163 | 8,620 | 74 | 0.74 | $1,157,595 | $258,627 |
| 2021 | 152 | 6,713 | 73 | 0.64 | $1,032,868 | $237,190 |
| 2020 | 128 | 6,350 | 73 | 0.66 | $902,409 | $210,794 |
| 2019 | 121 | 2,162 | 73 | 0.87 | $665,116 | $125,844 |
| 2018 | 105 | 1,323 | 73 | 0.84 | $582,828 | $108,126 |
| 2017 | 97 | 1,842 | 72 | 0.69 | $482,855 | $102,847 |
| 2016 | 88 | 766 | 72 | 1.00 | $171,745 | $55,364 |
| 2015 | 81 | 641 | 71 | 0.73 | $93,049 | $54,925 |
| 2014 | 64 | 524 | 73 | 0.81 | $74,599 | $43,223 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 15 services
| Hyaluronan or derivative, monovisc, for intra-articular injection, per dose | 33 | $26,967 | None |
| Hyaluronan or derivative, hymovis, for intra-articular injection, 1 mg | 23 | $25,631 | None |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 78 | $23,484 | $93 |
| Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg | 41 | $23,120 | None |
| Return visit (30+ min) | 82 | $18,217 | $112 |
| Long return visit (40+ min) | 70 | $16,454 | $150 |
| Complete ultrasound scan of joint | 81 | $12,305 | $49 |
| New patient visit (60+ min) | 42 | $7,554 | $180 |
| New patient visit (45+ min) | 26 | $3,779 | $145 |
| Aspiration and/or injection of fluid from large joint | 36 | $2,560 | $58 |
| Imaging guidance for procedure, 60 minutes or less | 38 | $2,219 | $44 |
| Mri scan of leg joint without contrast | 13 | $753 | $58 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 12 | $94 | None |
| Injection, dexamethasone sodium phosphate, 1 mg | 21 | $36 | None |
| Injection, lidocaine hcl for intravenous infusion, 10 mg | 36 | $1 | None |
2022: 13 services
| Hyaluronan or derivative, hymovis, for intra-articular injection, 1 mg | 46 | $75,929 | None |
| Return visit (30+ min) | 112 | $34,550 | $112 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 81 | $29,257 | $94 |
| Complete ultrasound scan of joint | 86 | $18,231 | $57 |
| Long return visit (40+ min) | 72 | $16,932 | $157 |
| Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg | 22 | $15,666 | None |
| Hyaluronan or derivative, monovisc, for intra-articular injection, per dose | 18 | $14,882 | None |
| New patient visit (60+ min) | 53 | $9,281 | $175 |
| Imaging guidance for procedure, 60 minutes or less | 32 | $2,004 | $42 |
| New patient visit (45+ min) | 13 | $1,781 | $137 |
| Aspiration and/or injection of fluid from large joint | 18 | $1,196 | $57 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 16 | $139 | None |
| Injection, dexamethasone sodium phosphate, 1 mg | 21 | $31 | None |
2021: 11 services
| Hyaluronan or derivative, hymovis, for intra-articular injection, 1 mg | 42 | $85,128 | None |
| Return visit (30+ min) | 122 | $46,358 | $116 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 82 | $27,205 | $93 |
| Complete ultrasound scan of joint | 88 | $18,861 | $64 |
| New patient visit (45+ min) | 52 | $7,084 | $136 |
| Long return visit (40+ min) | 18 | $3,341 | $167 |
| New patient visit (60+ min) | 16 | $3,283 | $205 |
| Imaging guidance for procedure, 60 minutes or less | 39 | $2,546 | $41 |
| Short return visit (20+ min) | 26 | $2,052 | $68 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 29 | $319 | None |
| Injection, dexamethasone sodium phosphate, 1 mg | 33 | $75 | None |
2020: 11 services
| Hyaluronan or derivative, hymovis, for intra-articular injection, 1 mg | 50 | $96,944 | None |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 76 | $22,688 | $93 |
| Complete ultrasound scan of joint | 83 | $16,953 | $73 |
| Return visit (30+ min) | 88 | $13,252 | $95 |
| New patient visit (45+ min) | 51 | $6,994 | $137 |
| Short return visit (20+ min) | 60 | $6,152 | $67 |
| Imaging guidance for procedure, 60 minutes or less | 46 | $2,463 | $41 |
| New patient visit (30+ min) | 12 | $993 | $83 |
| Mri scan of leg joint without contrast | 16 | $983 | $61 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 14 | $158 | None |
| Injection, dexamethasone sodium phosphate, 1 mg | 28 | $51 | None |
2019: 14 services
| Complete ultrasound scan of joint | 74 | $22,648 | $86 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 59 | $20,356 | $86 |
| Return visit (30+ min) | 77 | $15,851 | $95 |
| Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | 24 | $10,752 | None |
| Short return visit (20+ min) | 42 | $8,104 | $67 |
| Hyaluronan or derivative, gel-one, for intra-articular injection, per dose | 11 | $6,194 | None |
| New patient visit (45+ min) | 34 | $4,918 | $145 |
| New patient visit (60+ min) | 24 | $4,080 | $170 |
| Imaging guidance for procedure, 60 minutes or less | 29 | $1,601 | $44 |
| Long return visit (40+ min) | 11 | $1,549 | $119 |
| Mri scan of leg joint without contrast | 16 | $1,022 | $60 |
| Mri scan of arm joint without contrast | 13 | $994 | $55 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 25 | $297 | None |
| Injection, dexamethasone sodium phosphate, 1 mg | 20 | $44 | None |
2018: 14 services
| Complete ultrasound scan of joint | 75 | $20,900 | $94 |
| Return visit (30+ min) | 69 | $14,377 | $89 |
| Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | 18 | $7,764 | None |
| New patient visit (60+ min) | 45 | $7,358 | $164 |
| Aspiration and/or injection of fluid from large joint | 45 | $7,152 | $52 |
| Short return visit (20+ min) | 30 | $6,442 | $63 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 30 | $5,175 | $80 |
| Long return visit (40+ min) | 26 | $4,212 | $117 |
| New patient visit (45+ min) | 16 | $1,984 | $124 |
| Mri scan of arm joint without contrast | 19 | $1,362 | $57 |
| Imaging guidance for procedure, 60 minutes or less | 20 | $1,342 | $45 |
| Mri scan of leg joint without contrast | 12 | $798 | $57 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 23 | $104 | None |
| Injection, dexamethasone sodium phosphate, 1 mg | 28 | $13 | None |
2017: 10 services
| Complete ultrasound scan of joint | 63 | $22,993 | $111 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 52 | $14,862 | $80 |
| Return visit (30+ min) | 64 | $11,522 | $89 |
| Short return visit (20+ min) | 48 | $9,230 | $63 |
| Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | 14 | $6,512 | None |
| New patient visit (60+ min) | 38 | $6,315 | $166 |
| New patient visit (45+ min) | 20 | $2,548 | $127 |
| Mri scan of leg joint without contrast | 19 | $1,089 | $57 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 14 | $169 | None |
| Injection, dexamethasone sodium phosphate, 1 mg | 39 | $66 | None |
2016: 7 services
| New patient visit (60+ min) | 50 | $8,926 | $179 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 31 | $6,782 | $82 |
| Return visit (30+ min) | 40 | $5,889 | $95 |
| Long return visit (40+ min) | 28 | $5,490 | $125 |
| Complete ultrasound scan of joint | 19 | $4,529 | $108 |
| Short return visit (20+ min) | 16 | $2,361 | $66 |
| Injection, dexamethasone sodium phosphate, 1 mg | 15 | $22 | None |
2015: 8 services
| Long return visit (40+ min) | 38 | $8,899 | $122 |
| New patient visit (60+ min) | 50 | $8,814 | $176 |
| Return visit (30+ min) | 42 | $6,549 | $99 |
| Aspiration and/or injection of fluid from large joint | 32 | $3,591 | $55 |
| Ultrasonic guidance for needle placement | 29 | $3,309 | $57 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 18 | $3,172 | $86 |
| X-ray of shoulder, minimum of 2 views | 12 | $113 | $8 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 18 | $113 | None |
2014: 7 services
| Return visit (30+ min) | 25 | $6,572 | $101 |
| New patient visit (60+ min) | 23 | $4,255 | $185 |
| Aspiration and/or injection of fluid from large joint | 34 | $3,797 | $56 |
| New patient visit (45+ min) | 24 | $3,678 | $153 |
| Ultrasonic guidance for needle placement | 24 | $3,213 | $73 |
| Long return visit (40+ min) | 15 | $2,288 | $135 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 33 | $228 | None |
Drugs they prescribed that Part D paid
$2,436
Pharmacies billed $2,436 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 44% of their Part D prescriptions (14 of 32) in 2024. Too few prescriptions to judge: with under about 50 a year, a handful of patients can swing this share.
32 generic and 0 brand-name prescriptions · $2,436 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Hydrocodone-Acetaminophen | 11 | $110 | $10 |
Year by year
| 2024 | 32 | 20 | 44% (14) | 0% | $2,436 |
| 2023 | 44 | 21 | 34% (15) | None | $776 |
| 2022 | 48 | 23 | 35% (17) | 0% | $1,795 |
| 2021 | 84 | 29 | 31% (26) | 0% | $2,075 |
| 2020 | 62 | 34 | 42% (26) | None | $1,399 |
| 2019 | 40 | 23 | 38% (15) | None | $1,461 |
| 2018 | 64 | 29 | 39% (25) | None | $5,146 |
| 2017 | 48 | 24 | 38% (18) | None | $2,807 |
| 2016 | 41 | 15 | 37% (15) | None | $1,148 |
| 2015 | 29 | 15 | 62% (18) | 0% | $470 |
| 2014 | 25 | None | 68% (17) | 0% | $374 |
| 2013 | 95 | 42 | 41% (39) | None | $1,722 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2022: 2 drugs
| Celecoxib | 13 | $707 | $54 |
| Hydrocodone-Acetaminophen | 12 | $113 | $9 |
2021: 2 drugs
| Celecoxib | 28 | $1,224 | $44 |
| Hydrocodone-Acetaminophen | 16 | $115 | $7 |
2020: 2 drugs
| Celecoxib | 17 | $961 | $57 |
| Hydrocodone-Acetaminophen | 19 | $129 | $7 |
2019: 1 drug
| Celecoxib | 13 | $1,007 | $77 |
2018: 2 drugs
| Celecoxib | 19 | $4,126 | $217 |
| Hydrocodone-Acetaminophen | 14 | $100 | $7 |
2017: 2 drugs
| Celecoxib | 18 | $2,237 | $124 |
| Hydrocodone-Acetaminophen | 14 | $162 | $12 |
2014: 1 drug
| Hydrocodone-Acetaminophen | 15 | $324 | $22 |
2013: 3 drugs
| Hydrocodone-Acetaminophen | 28 | $352 | $13 |
| Cephalexin | 22 | $179 | $8 |
| Temazepam | 11 | $151 | $14 |
Money from drug and device companies
$64 in 2025
| 2025 | 2 | 2 | None | $64 |
| 2024 | 3 | 3 | None | $177 |
| 2023 | 5 | 18 | None | $1,568 |
| 2022 | 3 | 3 | None | $71 |
| 2021 | 2 | 2 | None | $61 |
| 2020 | 4 | 4 | None | $4,165 |
| 2019 | 3 | 3 | None | $194 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Flower Orthopedics Coporation | None | $40 | 1 payment
|
| Orthofix Medical | Physio-Stim | $23 | 1 payment
|
See all 2 published payments
| Flower Orthopedics Coporation | Meals · 2025-10-29 | None | $40 |
| Orthofix Medical | Meals · 2025-06-25 | Physio-Stim | $23 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $177
| Arthrex | None | $138 | 1 payment
|
| Fidia Pharma USA | Hymovis | $22 | 1 payment
|
| Bioventus | Exogen Ultrasound Bone Healing System | $17 | 1 payment
|
2023: $1,568
| Arthrex | Shoulder Implants Fibertak Knotless | $1,198 | 14 payments
|
| Evolution Surgical | None | $143 | 1 payment
|
| Miach Orthopaedics | None | $138 | 1 payment
|
| Smith+Nephew | Acufex | $76 | 1 payment
|
| Bioventus | Supartz Fx Sodium Hyaluronate | $14 | 1 payment
|
2022: $71
| Bioventus | Exogen Ultrasound Bone Healing System | $30 | 1 payment
|
| Fidia Pharma USA | Hymovis | $21 | 1 payment
|
| Pacira Pharmaceuticals | Iovera | $21 | 1 payment
|
2021: $61
| Pacira Therapeutics | Zilretta | $33 | 1 payment
|
| Bioventus | Durolane | $28 | 1 payment
|
2020: $4,165
| Zimmer Biomet Holdings | Zimmer Biomet Instruments and Implants | $4,000 | 1 payment
|
| Arthrex | Biologics Consumables Accessories Acp Prp | $114 | 1 payment
|
| Integra LifeSciences | Cadence Ankle Replacement System | $29 | 1 payment
|
| Boston Scientific | Renegade | $22 | 1 payment
|
2019: $194
| Wright Medical Technology | Perform Glenoid | $157 | 1 payment
|
| Fidia Pharma USA | Hymovis | $19 | 1 payment
|
| Bioventus | Gelsyn 3 | $18 | 1 payment
|
Professional record
- NPI
- 1821212366
- Licence
- CA A98300California A98300: Current · expires 2028-08-31
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Orthopedic surgery (207X00000X)
- Mailing address
- 2299 Post St Ste 107, San Francisco, CA, 94115
- NPI first listed
- 2007-04-13
- NPI last updated
- 2021-03-15
- NPI record certified
- 2021-03-15
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 1028 Sir Francis Drake Blvd, Kentfield, CA, 94904